A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Comments on the section "Cardiovascular risk estimation" in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice
2022
CARDIOVASCULAR THERAPY AND PREVENTION
The article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. Two novel risk charts (SCORE2 and SCORE2-OP) have been proposed that have undergone significant revision and require significant changes in primary care practice. It has been suggested that in modern conditions their practical introduction is premature, since the healthcare system is not ready for renewal. Therefore, time is needed to adapt it to the practical
doi:10.15829/1728-8800-2022-3171
doaj:9e05d7ca5adf47ea948394ae6d485b8a
fatcat:75ffiu6bc5eltac56gf2723mra